Ultracod – Medicinal Product Register of Latvia

Paracetamolum, Codeini phosphas hemihydricus

Search by the name of the active substance

Return to the results

Medicinal product name

Ultracod 500 mg/30 mg tablets

Pharmaceutical form

Tablet

Strength

500 mg/30 mg

Information from the MAH on shortages

No information on expected shortages

Availability of medicinal product

Product No.	Package size	Wholesalers' stock state
08-0234-01	N10	Is available
08-0234-03	N30	Is available

Legal status

Rx Prescription (Pr.)

Package leaflet

12-07-2022

Summary of product characteristics

12-07-2022

ATC code

N02AJ06 – Analgesics

Important notice

Additional information regarding the use for persons aged 75+

If used as "ANALGESICS"
Substance	Class	Comment
Paracetamolum	A	Suitable for older adults. Maximum dose in regular use 2–3 grams per day. Consider paracetamol in OTC drugs and combination products. Overdose is hepatotoxic. Concurrent use of over 2 grams with warfarin is possible only if INR values are monitored.
Codeini phosphas hemihydricus	D	Avoid use in older adults. Sedative. Prodrug. Genotype affects the response. Increases the risk of confusion and falling. Start a laxative to prevent constipation. Consider potential interactions.

Medicinal products (5)

Display only medicinal products with a declared price

Display only medicinal products available in wholesalers' stock

Availability of medicinal product	Wholesalers	Package size, content	Primary packaging	Maximum admissible pharmacy price (€ incl. VAT)	Product No.	Labelling
Is available (according to the information provided by wholesalers) (1066 containers)	Tamro, Recipe Plus, Magnum Medical, Saules aptieka, Baltfarm "Vita-Farm", Oribalt Rīga, Euroaptieka	N10 (500 mg/30 mg)	PVC/PVDC/Al blister	€ 6.31	08-0234-01	Labelling text Jul 12, 2022
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N20 (500 mg/30 mg)	PVC/PVDC/Al blister		08-0234-02	Labelling text Jul 12, 2022
Is available (according to the information provided by wholesalers) (4836 containers)	Tamro, Magnum Medical, Saules aptieka, Baltfarm "Vita-Farm", Jelgavfarm, Oribalt Rīga, Euroaptieka	N30 (500 mg/30 mg)	PVC/PVDC/Al blister	€ 13.48	08-0234-03	Labelling text Jul 12, 2022
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N60 (500 mg/30 mg)	PVC/PVDC/Al blister		08-0234-04	Labelling text Jul 12, 2022
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N100 (500 mg/30 mg)	PVC/PVDC/Al blister		08-0234-05	Labelling text Jul 12, 2022

Registration information

Marketing authorisation No.	08-0234
Date of authorisation	Sep 25, 2008
Marketing authorisation holder, country	Zentiva, k.s., Czech Republic

Return to the results

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on May 18, 2024.